KPW
TAK icon

Kore Private Wealth’s Takeda Pharmaceutical TAK Stock Holding History

Kore Private Wealth’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-14,136
Closed -$232K – 439
2021
Q3 		$232K Buy
+14,136
New +$237K 0.02% 392
2020
Q3 		– Sell
-2,300
Closed -$41K – 981
2020
Q2 		$41K Sell
2,300
-148
-6% -$2.66K 0.01% 501
2020
Q1 		$37K Buy
2,448
+585
+31% +$10.6K 0.01% 477
2019
Q4 		$37K Buy
+1,863
New +$35.6K 0.01% 521
2019
Q2 		– Sell
-745
Closed -$15K – 717
2019
Q1 		$15K Buy
+745
New +$15K ﹤0.01% 549

Other funds holding TAK

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BCP
BSN Capital Partners London, United Kingdom $3.93B AUM 13.09% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Kore Private Wealth's TAK Position: Q4 2021 in Review

Kore Private Wealth sold out of Takeda Pharmaceutical (TAK) in Q4 2021, closing a stake of 14,136 shares — an estimated $232K sold.

Kore Private Wealth first reported a position in TAK in Q1 2019 and held it in 5 quarters. The position peaked at $232K in Q3 2021. 298 funds tracked by Wall St. Rank hold TAK as of Q4 2021.

  • Kore Private Wealth reported no remaining Takeda Pharmaceutical position as of Q4 2021 after selling out during the quarter.
  • Kore Private Wealth sold 14,136 Takeda Pharmaceutical shares in Q4 2021, an estimated $232K.
  • Kore Private Wealth first reported a position in Takeda Pharmaceutical in Q1 2019 and held it in 5 quarters.
  • Kore Private Wealth's Takeda Pharmaceutical position peaked at $232K in Q3 2021.
  • 298 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q4 2021.

Based on Kore Private Wealth's 13F filing for Q4 2021, filed 11 Feb 2022.